Swiss National Bank Purchases 200 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

Swiss National Bank raised its position in shares of Addus HomeCare Co. (NASDAQ:ADUS) by 0.6% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 35,600 shares of the company’s stock after purchasing an additional 200 shares during the period. Swiss National Bank owned about 0.20% of Addus HomeCare worth $4,462,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also made changes to their positions in the company. Connor Clark & Lunn Investment Management Ltd. bought a new position in shares of Addus HomeCare during the third quarter valued at approximately $1,622,000. JPMorgan Chase & Co. raised its stake in Addus HomeCare by 10.2% in the third quarter. JPMorgan Chase & Co. now owns 183,198 shares of the company’s stock worth $24,371,000 after buying an additional 16,997 shares in the last quarter. Principal Financial Group Inc. lifted its holdings in Addus HomeCare by 17.5% during the third quarter. Principal Financial Group Inc. now owns 505,853 shares of the company’s stock worth $67,293,000 after buying an additional 75,409 shares during the period. Cherry Creek Investment Advisors Inc. bought a new stake in Addus HomeCare during the 4th quarter valued at $340,000. Finally, Barclays PLC increased its holdings in shares of Addus HomeCare by 204.8% in the 3rd quarter. Barclays PLC now owns 43,470 shares of the company’s stock valued at $5,783,000 after acquiring an additional 29,207 shares during the period. 95.35% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

ADUS has been the topic of a number of recent research reports. Stephens reaffirmed an “overweight” rating and set a $142.00 price objective on shares of Addus HomeCare in a research report on Wednesday, March 12th. StockNews.com cut shares of Addus HomeCare from a “buy” rating to a “hold” rating in a report on Wednesday, February 26th. JMP Securities assumed coverage on shares of Addus HomeCare in a research note on Monday, December 16th. They set an “outperform” rating and a $150.00 price objective for the company. Macquarie restated an “outperform” rating and issued a $129.00 target price on shares of Addus HomeCare in a research note on Thursday, February 27th. Finally, Oppenheimer upped their price target on Addus HomeCare from $145.00 to $150.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, seven have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $132.78.

Insider Buying and Selling

In related news, CEO R Dirk Allison sold 25,000 shares of the firm’s stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $124.76, for a total transaction of $3,119,000.00. Following the completion of the transaction, the chief executive officer now owns 79,397 shares of the company’s stock, valued at $9,905,569.72. This trade represents a 23.95 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Corporate insiders own 4.60% of the company’s stock.

Addus HomeCare Trading Up 4.4 %

NASDAQ:ADUS opened at $95.01 on Wednesday. The company has a market capitalization of $1.73 billion, a P/E ratio of 21.74, a PEG ratio of 1.41 and a beta of 0.97. Addus HomeCare Co. has a 12 month low of $87.88 and a 12 month high of $136.72. The firm has a fifty day simple moving average of $110.45 and a 200-day simple moving average of $121.26.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings results on Monday, February 24th. The company reported $1.26 EPS for the quarter, missing analysts’ consensus estimates of $1.35 by ($0.09). The firm had revenue of $297.14 million for the quarter, compared to analyst estimates of $291.04 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. Equities analysts forecast that Addus HomeCare Co. will post 4.59 EPS for the current year.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.